Sci Transl Med. 2010 Apr 21;2(28):28cm13. doi: 10.1126/scitranslmed.3000643.

Refocusing the war on cancer: the critical role of personalized treatment.

Source

Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27708, USA.

Abstract

Despite very substantial investment and effort over the past 30 years, the overall survival rate of cancer patients has changed little. We propose that without a truly robust mechanism for selecting the right treatment for the right patient at the right time-the central concepts of personalized medicine-we will continue to see only incremental improvements and have little hope for substantial survival gains. We suggest that it is now imperative that future clinical trials be designed with a plan to incorporate biomarker development.

PMID:: 20410527; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Personalized medicine in oncology: tailoring the right drug to the right patient. [Biomark Med. 2010]
Review Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y, Wang M. Biomark Med. 2010 Aug; 4(4):523-33.
From genomic landscapes to personalized cancer management-is there a roadmap? [Ann N Y Acad Sci. 2010]
From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C, Caldas C. Ann N Y Acad Sci. 2010 Oct; 1210:34-44.
Review Cancer biomarkers: selecting the right drug for the right patient. [Nat Rev Drug Discov. 2012]
Review Cancer biomarkers: selecting the right drug for the right patient.
Kelloff GJ, Sigman CC. Nat Rev Drug Discov. 2012 Feb 10; 11(3):201-14. Epub 2012 Feb 10.
Personalized medicine in oncology: the future is now. [Nat Rev Drug Discov. 2010]
Personalized medicine in oncology: the future is now.
Schilsky RL. Nat Rev Drug Discov. 2010 May; 9(5):363-6.
Translating cancer research into targeted therapeutics. [Nature. 2010]
Translating cancer research into targeted therapeutics.
de Bono JS, Ashworth A. Nature. 2010 Sep 30; 467(7315):543-9.

See reviews... See all...

Cited by 4 PubMed Central articles

Cancer, inflammation, and insights from ayurveda. [Evid Based Complement Alternat...]
Cancer, inflammation, and insights from ayurveda.
Sumantran VN, Tillu G. Evid Based Complement Alternat Med. 2012; 2012:306346. Epub 2012 Jul 4.
Personalized therapy for pancreatic cancer: Myth or reality in 2010? [J Gastrointest Oncol. 2010]
Personalized therapy for pancreatic cancer: Myth or reality in 2010?
Huang TC, Kar S, Javle M. J Gastrointest Oncol. 2010 Sep; 1(1):24-33.
Review Intracellular delivery of RNA-based therapeutics using aptamers. [Ther Deliv. 2010]
Review Intracellular delivery of RNA-based therapeutics using aptamers.
Thiel KW, Giangrande PH. Ther Deliv. 2010 Dec; 1(6):849-61.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Refocusing the war on cancer: the critical role of personalized treatment.
Refocusing the war on cancer: the critical role of personalized treatment.
Sci Transl Med. 2010 Apr 21 ;2(28):28cm13. doi: 10.1126/scitranslmed.3000643.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: